LPL Financial’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$277K Buy
15,587
+3,626
+30% +$64.5K ﹤0.01% 4715
2025
Q1
$213K Sell
11,961
-15,900
-57% -$283K ﹤0.01% 4702
2024
Q4
$830K Buy
+27,861
New +$830K ﹤0.01% 3614
2024
Q3
Sell
-14,651
Closed -$251K 5132
2024
Q2
$251K Sell
14,651
-3,117
-18% -$53.4K ﹤0.01% 4310
2024
Q1
$278K Sell
17,768
-2,940
-14% -$46K ﹤0.01% 4194
2023
Q4
$309K Buy
20,708
+5,144
+33% +$76.8K ﹤0.01% 4014
2023
Q3
$251K Sell
15,564
-7,776
-33% -$126K ﹤0.01% 4023
2023
Q2
$969K Sell
23,340
-726
-3% -$30.1K ﹤0.01% 2837
2023
Q1
$1.45M Sell
24,066
-770
-3% -$46.3K ﹤0.01% 2434
2022
Q4
$1.82M Buy
24,836
+2,670
+12% +$196K ﹤0.01% 2134
2022
Q3
$1.68M Buy
22,166
+2,805
+14% +$213K ﹤0.01% 2106
2022
Q2
$1.35M Buy
19,361
+652
+3% +$45.3K ﹤0.01% 2327
2022
Q1
$1.55M Sell
18,709
-4,287
-19% -$355K ﹤0.01% 2236
2021
Q4
$1.73M Buy
22,996
+521
+2% +$39.1K ﹤0.01% 2194
2021
Q3
$2.61M Buy
22,475
+5,345
+31% +$621K ﹤0.01% 1841
2021
Q2
$3.8M Sell
17,130
-303
-2% -$67.2K ﹤0.01% 1533
2021
Q1
$2.3M Sell
17,433
-7,216
-29% -$954K ﹤0.01% 1741
2020
Q4
$4.27M Sell
24,649
-910
-4% -$157K 0.01% 1203
2020
Q3
$2.85M Buy
25,559
+1,510
+6% +$168K ﹤0.01% 1267
2020
Q2
$1.43M Buy
24,049
+3,791
+19% +$225K ﹤0.01% 1566
2020
Q1
$1.36M Buy
20,258
+4,619
+30% +$311K ﹤0.01% 1422
2019
Q4
$1.32M Buy
15,639
+391
+3% +$33K ﹤0.01% 1649
2019
Q3
$1.14M Sell
15,248
-8,716
-36% -$652K ﹤0.01% 1627
2019
Q2
$1.52M Buy
23,964
+10,268
+75% +$649K ﹤0.01% 1426
2019
Q1
$660K Sell
13,696
-87
-0.6% -$4.19K ﹤0.01% 1972
2018
Q4
$461K Buy
+13,783
New +$461K ﹤0.01% 2091